v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 6 Months Ended
Jun. 27, 2026
Jun. 28, 2025
Jun. 27, 2026
Jun. 28, 2025
Income Statement [Abstract]        
Net revenues $ 68,832,000 $ 74,958,000 $ 127,038,000 $ 143,689,000
Cost of goods sold 62,959,000 67,038,000 119,180,000 142,694,000
Gross profit 5,873,000 7,920,000 7,858,000 995,000
Operating expenses:        
Research and development expenses 4,189,000 5,807,000 9,409,000 13,269,000
Selling, general and administrative expenses 32,490,000 39,628,000 70,359,000 89,610,000
Total operating expenses 36,679,000 45,435,000 79,768,000 102,879,000
Loss from operations (30,806,000) (37,515,000) (71,910,000) (101,884,000)
Other income (expense), net:        
Interest expense (6,571,000) (2,002,000) (13,303,000) (3,026,000)
Remeasurement of delayed draw term loan warrant liability (76,000) 0 1,224,000 0
Remeasurement of derivative liability (3,838,000) 0 8,053,000 0
Gain on debt extinguishment 57,729,000 0 63,789,000 0
Other (expense) income, net (18,000) 7,731,000 101,000 12,049,000
Total other income, net 47,226,000 5,729,000 59,864,000 9,023,000
Income (loss) before taxes 16,420,000 (31,786,000) (12,046,000) (92,861,000)
Income tax expense 0 0 0 0
Equity in losses of unconsolidated joint venture 16,000 59,000 32,000 70,000
Net income (loss) $ 16,404,000 $ (31,845,000) $ (12,078,000) $ (92,931,000)
Net income (loss) per share available to common stockholders—basic (in dollars per share) $ 0.03 $ (0.42) $ (0.03) $ (1.22)
Net loss per share available to common stockholders—diluted (in dollars per share) $ (0.06) $ (0.42) $ (0.03) $ (1.22)
Weighted average common shares outstanding — basic (in shares) 501,304,934 76,491,594 476,742,903 76,348,524
Weighted average common shares outstanding — diluted (in shares) 591,868,891 76,491,594 476,742,903 76,348,524